Peri-operative blood-loss after total hip arthroplasty can be significantly reduced with topical application of epsilon-aminocaproic acid

Mark G. Sucher, Mauro Giordani, Andrew Figoni, Alexander J. Nedopil

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Purpose: To evaluate the peri-operative blood loss with the use of epsilon-aminocaproic acid (ε-ACA) in total hip arthroplasty (THA). Methods: One hundred sixty patients treated with THA were followed; 5 g ε-ACA diluted in 100 ml normal saline was applied intra-operatively. Eighty patients not receiving ε-ACA (non ε-ACA group) and eighty patients receiving ε-ACA (ε-ACA group) were compared regarding blood loss, need of transfusion, and thrombo-embolic complications. Results: Blood loss (mean ± SD) for the non ε-ACA group was 1678 ± 515 ml and for the ε-ACA group 1403 ± 417 ml (p <0.05). In the non ε-ACA group 23 patients needed blood transfusions compared to ten patients in the ε-ACA group (p <0.05). Cost savings were $284.39 per patient. No patient in either group developed a thrombo-embolic complication. Conclusions: This study demonstrates a significant reduction in peri-operative blood loss after THA with topically applied ε-ACA. The application of ε-ACA reduced costs by lowering transfusion rates and did not increase thrombo-embolic events. ε-ACA is safe and effective in reducing blood loss and cost-efficient in THA.

Original languageEnglish (US)
Pages (from-to)1-5
Number of pages5
JournalInternational Orthopaedics
DOIs
StateAccepted/In press - Jan 8 2016

Fingerprint

Aminocaproic Acid
Arthroplasty
Hip
Costs and Cost Analysis
Cost Savings
Blood Transfusion

Keywords

  • Blood loss
  • Epsilon-aminocaproic acid
  • Total hip arthroplasty

ASJC Scopus subject areas

  • Orthopedics and Sports Medicine

Cite this

Peri-operative blood-loss after total hip arthroplasty can be significantly reduced with topical application of epsilon-aminocaproic acid. / Sucher, Mark G.; Giordani, Mauro; Figoni, Andrew; Nedopil, Alexander J.

In: International Orthopaedics, 08.01.2016, p. 1-5.

Research output: Contribution to journalArticle

@article{6eea3ecf58a8404fb4efb5c7f0669ba8,
title = "Peri-operative blood-loss after total hip arthroplasty can be significantly reduced with topical application of epsilon-aminocaproic acid",
abstract = "Purpose: To evaluate the peri-operative blood loss with the use of epsilon-aminocaproic acid (ε-ACA) in total hip arthroplasty (THA). Methods: One hundred sixty patients treated with THA were followed; 5 g ε-ACA diluted in 100 ml normal saline was applied intra-operatively. Eighty patients not receiving ε-ACA (non ε-ACA group) and eighty patients receiving ε-ACA (ε-ACA group) were compared regarding blood loss, need of transfusion, and thrombo-embolic complications. Results: Blood loss (mean ± SD) for the non ε-ACA group was 1678 ± 515 ml and for the ε-ACA group 1403 ± 417 ml (p <0.05). In the non ε-ACA group 23 patients needed blood transfusions compared to ten patients in the ε-ACA group (p <0.05). Cost savings were $284.39 per patient. No patient in either group developed a thrombo-embolic complication. Conclusions: This study demonstrates a significant reduction in peri-operative blood loss after THA with topically applied ε-ACA. The application of ε-ACA reduced costs by lowering transfusion rates and did not increase thrombo-embolic events. ε-ACA is safe and effective in reducing blood loss and cost-efficient in THA.",
keywords = "Blood loss, Epsilon-aminocaproic acid, Total hip arthroplasty",
author = "Sucher, {Mark G.} and Mauro Giordani and Andrew Figoni and Nedopil, {Alexander J.}",
year = "2016",
month = "1",
day = "8",
doi = "10.1007/s00264-015-3103-1",
language = "English (US)",
pages = "1--5",
journal = "International Orthopaedics",
issn = "0341-2695",
publisher = "Springer Verlag",

}

TY - JOUR

T1 - Peri-operative blood-loss after total hip arthroplasty can be significantly reduced with topical application of epsilon-aminocaproic acid

AU - Sucher, Mark G.

AU - Giordani, Mauro

AU - Figoni, Andrew

AU - Nedopil, Alexander J.

PY - 2016/1/8

Y1 - 2016/1/8

N2 - Purpose: To evaluate the peri-operative blood loss with the use of epsilon-aminocaproic acid (ε-ACA) in total hip arthroplasty (THA). Methods: One hundred sixty patients treated with THA were followed; 5 g ε-ACA diluted in 100 ml normal saline was applied intra-operatively. Eighty patients not receiving ε-ACA (non ε-ACA group) and eighty patients receiving ε-ACA (ε-ACA group) were compared regarding blood loss, need of transfusion, and thrombo-embolic complications. Results: Blood loss (mean ± SD) for the non ε-ACA group was 1678 ± 515 ml and for the ε-ACA group 1403 ± 417 ml (p <0.05). In the non ε-ACA group 23 patients needed blood transfusions compared to ten patients in the ε-ACA group (p <0.05). Cost savings were $284.39 per patient. No patient in either group developed a thrombo-embolic complication. Conclusions: This study demonstrates a significant reduction in peri-operative blood loss after THA with topically applied ε-ACA. The application of ε-ACA reduced costs by lowering transfusion rates and did not increase thrombo-embolic events. ε-ACA is safe and effective in reducing blood loss and cost-efficient in THA.

AB - Purpose: To evaluate the peri-operative blood loss with the use of epsilon-aminocaproic acid (ε-ACA) in total hip arthroplasty (THA). Methods: One hundred sixty patients treated with THA were followed; 5 g ε-ACA diluted in 100 ml normal saline was applied intra-operatively. Eighty patients not receiving ε-ACA (non ε-ACA group) and eighty patients receiving ε-ACA (ε-ACA group) were compared regarding blood loss, need of transfusion, and thrombo-embolic complications. Results: Blood loss (mean ± SD) for the non ε-ACA group was 1678 ± 515 ml and for the ε-ACA group 1403 ± 417 ml (p <0.05). In the non ε-ACA group 23 patients needed blood transfusions compared to ten patients in the ε-ACA group (p <0.05). Cost savings were $284.39 per patient. No patient in either group developed a thrombo-embolic complication. Conclusions: This study demonstrates a significant reduction in peri-operative blood loss after THA with topically applied ε-ACA. The application of ε-ACA reduced costs by lowering transfusion rates and did not increase thrombo-embolic events. ε-ACA is safe and effective in reducing blood loss and cost-efficient in THA.

KW - Blood loss

KW - Epsilon-aminocaproic acid

KW - Total hip arthroplasty

UR - http://www.scopus.com/inward/record.url?scp=84953393595&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84953393595&partnerID=8YFLogxK

U2 - 10.1007/s00264-015-3103-1

DO - 10.1007/s00264-015-3103-1

M3 - Article

SP - 1

EP - 5

JO - International Orthopaedics

JF - International Orthopaedics

SN - 0341-2695

ER -